FRANCE: SANOFI-SYNTHELABO MANAGEMENT SHUFFLE

Article Abstract:

Jean-Claude Armbruster has replaced Marie-Helene Laimay as president of Sanofi-Synthelabo Groupe, a Paris-based pharmaceutical group which has a capital stock of FFr 250,000. Jean-Pierre Charoy has been named managing director of the Synthelabo Groupe company, which has a capital stock of FFr 194,266,800 and is located at Le Plessis-Robinson.

SANOFI-SYNTHELABO MANAGEMENT

---

FRANCE: NEW HEAD OF SYNTHELABO RECHERCHE

Article Abstract:

Gerard Le Fur has replaced Jean Marsac as president of Synthelabo Recherche.

---

France: Sanofi-Synthelabo group names two men

Article Abstract:

Groupement de fabrication pharmaceutique has named Didier Rousselle as chairman. He takes over from Philippe Fauchet for the job, while Christian Lajoux will take over from Bruno Garnier as chairman at Sanofi-Synthelabo OTC.

Publisher: Revue Hebdomadaire
Publication Name: Revue Hebdomadaire des Industries Chimiques
Subject: Chemicals, plastics and rubber industries
ISSN:
Year: 2001

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Proprietary Preparations, Proprietary drugs, Sanofi Synthelabo

User Contributions:

Comment about this article or add new information about this topic:

Public Comment:  (50-4000 characters)

Name:

E-mail:

Type the code shown:

Show my email publicly:

Subjects list: Drugs, France

Similar abstracts:

• Abstracts: Poland: Paint makers' profits fall in 2000. GERMANY: BUILDING INVESTMENT BY STO. AUSTRIA: INVESTMENTS BY ADLER
• Abstracts: EUROPE: HALOX BOOSTS PIGMENT SALES WITH ERBSLOH. AUSTRIA: IG PULVERTECHNIK SET UP BRANCH. CHINA: DEGUSSA TO BOOST OPERATIONS
• Abstracts: US: ELECTRONIC MARKETPLACE FOR POWDER COATINGS. US: RALPH LAUREN COATINGS BY GLIDDEN. US: PURCHASING ALLIANCE BY PAINT MAKERS

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.